Current scientific questions influencing patient management in advanced prostate cancer
17 July 2020 - 1 Hours

Current scientific questions influencing patient management in advanced prostate cancer

Learning objective:         

After joining this meeting, participants should be able to:

  • Describe the clinical benefits of earlier treatment of patients with metastatic hormone-sensitive prostate cancer (mHSPC) and non-metastatic castration-resistant prostate cancer (nmCRPC) and the consequences of disease progression
  • Discuss the impact of new data on treatment and management decisions for ...
more info...

EM-26511
Prostate cancer news June 2020: an expert view
3 June 2020 - 61 Minutes

Prostate cancer news June 2020: an expert view

Learning objectives:         

After watching this broadcast, participants should be able to:

  • Discuss and explain the new data on prostate cancer
  • Discuss how the new data will affect daily clinical practice

 

Scientific committee:

  • Heather Payne, UK
  • Kurt Miller, Germany

 

more info...

EM-31420
Prostate cancer news June 2020: an expert view
2 June 2020 - 61 Minutes

Prostate cancer news June 2020: an expert view

Learning objectives:         

After watching this broadcast, participants should be able to:

  • Discuss and explain the new data on prostate cancer
  • Discuss how the new data will affect daily clinical practice

 

Scientific committee:

  • Heather Payne, UK
  • Kurt Miller, Germany

 

more info...

EM-31420
The COVID-19 pandemic: implications for patients with advanced prostate cancer
6 May 2020 - 1 Hours

The COVID-19 pandemic: implications for patients with advanced prostate cancer

Learning objective:         

After watching this broadcast, participants should be able to:

  • Evaluate the management options for advanced prostate cancer patients during the current COVID-19 pandemic
  • Discuss the impact of the COVID-19 pandemic on patients and HCPs

 

Scientific committee:

  • Heather Payne, UK
  • Kurt Miller, Germany

 

more info...

EM -31245
Experts’ view on prostate cancer news from San Francisco 2020
14 February 2020 - 59 Minutes

Experts’ view on prostate cancer news from San Francisco 2020

Learning objective:         

After watching this broadcast, participants should be able to:

  • Discuss and explain new data on prostate cancer from San Francisco
  • Discuss how new data will alter daily clinical practice

 

Faculty:

  • Kurt Miller (Germany)
  • Heather Payne (UK)
  • Fred Saad (Canada)
  • Celestia Higano (USA)
more info...

EM-25197
Updates from Bladder cancer Congress in Paris
31 October 2019 - 66 Minutes

Updates from Bladder cancer Congress in Paris

Learning objectives:

After watching this broadcast, participants should be able to:

  • Discuss and explain data reviewed from Paris
  • Discuss how the data will alter your daily clinical practice

 

Faculty:

  • Alison Birtle (UK)
  • Antonio Lopez Beltran (Portugal)
  • Kilian M. Gust (Austria)
more info...

EM-15431
Urothelial cancer highlights from ESMO 2019
1 October 2019 - 59 Minutes

Urothelial cancer highlights from ESMO 2019

Learning objectives:

After watching this broadcast, participants should be able to:

  • Discuss and explain new data on urothelial cancer from ESMO
  • Discuss how new data from ESMO will alter daily clinical practice

 

Faculty:

  • Alison Birtle (UK)
  • Ignacio Durán (Spain)
  • Rob Jones (UK)
  • Yohann Loriot (France)
  • Arlene Siefker-Radtke (USA)
more info...

EM-15428
Prostate cancer highlights from ESMO 2019
1 October 2019 - 61 Minutes

Prostate cancer highlights from ESMO 2019

Learning objective:

After watching this broadcast, participants should be able to:

  • Discuss and explain new data on PC from ESMO
  • Discuss how new data will alter your daily clinical practice

 

Faculty:

  • Kurt Miller (Germany)
  • Heather Payne (UK)
  • Bertrand Tombal (Belgium)
  • Kim Chi (Canada)
  • Eleni Efstathiou (USA)
more info...

EM-15428
Expanding the therapeutic opportunities in advanced prostate cancer
29 September 2019 - 89 Minutes

Expanding the therapeutic opportunities in advanced prostate cancer

Learning objectives:

After attending this meeting, participants should be able to:

  • Discuss ongoing changes and the subsequent impact on the treatment landscape of advanced prostate cancer
  • Review advances in therapeutic strategies for mHSPC
  • Explore practical management of treatment options in nmCRPC

 

Faculty:

more info...

EM-15428
Integrating precision medicine: are we ready for a paradigm shift in advanced urothelial carcinoma?
27 September 2019 - 115 Minutes

Integrating precision medicine: are we ready for a paradigm shift in advanced urothelial carcinoma?

Learning objectives:

After attending this meeting, participants should be able to:

  • Differentiate current metastatic urothelial carcinoma treatment options and describe their applicability in clinical practice
  • Evaluate tumour biology, the role of biomarkers, and the challenges of advanced urothelial carcinoma from a multidisciplinary perspective
  • Describe how current research may drive therapeutic decisions for patients with advanced urothelial ...
more info...

EM-15428